Alisha E. Bellezza - 06 Mar 2023 Form 4 Insider Report for Chemours Co (CC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Mar 2023, 16:24:11 UTC
Prior SEC filing
10 Mar 2023
Next SEC filing
16 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Pauletta Brown, Attorney-in-Fact

Key filing fact

Alisha E. Bellezza filed Form 4 for Chemours Co (CC) on 07 Mar 2023.

Key facts

  • This page summarizes Alisha E. Bellezza's Form 4 filing for Chemours Co (CC).
  • 12 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 07 Mar 2023, 16:24.

Change

  • Previous filing in this sequence was filed on 10 Mar 2023.
  • Current net transaction value: -$324,820.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Options Exercise

Transaction value
$128,600
Shares
+8,912
Change %
+20%
Price
$14.43
Shares after
52,843
Date
06 Mar 2023
Ownership
Direct
Footnotes
F1
CC transaction

Common Stock

Sale

Transaction value
$316,109
Shares
-8,912
Change %
-17%
Price
$35.47
Shares after
43,931
Date
06 Mar 2023
Ownership
Direct
Footnotes
F1, F2
CC transaction

Common Stock

Options Exercise

Transaction value
$130,927
Shares
+5,453
Change %
+12%
Price
$24.01
Shares after
49,384
Date
06 Mar 2023
Ownership
Direct
Footnotes
F1
CC transaction

Common Stock

Sale

Transaction value
$193,418
Shares
-5,453
Change %
-11%
Price
$35.47
Shares after
43,931
Date
06 Mar 2023
Ownership
Direct
Footnotes
F1, F2
CC transaction

Common Stock

Options Exercise

Transaction value
$192,642
Shares
+7,415
Change %
+17%
Price
$25.98
Shares after
51,346
Date
06 Mar 2023
Ownership
Direct
Footnotes
F1
CC transaction

Common Stock

Sale

Transaction value
$263,010
Shares
-7,415
Change %
-14%
Price
$35.47
Shares after
43,931
Date
06 Mar 2023
Ownership
Direct
Footnotes
F1, F2
CC transaction

Common Stock

Options Exercise

Transaction value
$206,098
Shares
+5,936
Change %
+14%
Price
$34.72
Shares after
49,867
Date
06 Mar 2023
Ownership
Direct
Footnotes
F1
CC transaction

Common Stock

Sale

Transaction value
$210,550
Shares
-5,936
Change %
-12%
Price
$35.47
Shares after
43,931
Date
06 Mar 2023
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CC transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-8,912
Change %
-100%
Price
$0.000000*
Shares after
0
Date
06 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,912
Exercise price
$14.43
Footnotes
F3
CC transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-5,453
Change %
-50%
Price
$0.000000
Shares after
5,453
Date
06 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,453
Exercise price
$24.01
Footnotes
F4
CC transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-7,415
Change %
-33%
Price
$0.000000
Shares after
14,829
Date
06 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,415
Exercise price
$25.98
Footnotes
F5
CC transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-5,936
Change %
-100%
Price
$0.000000*
Shares after
0
Date
06 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,936
Exercise price
$34.72
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Includes directly owned shares, restricted stock units and dividend equivalent units.

Footnote F2

Shares were sold in multiple transactions at prices ranging from $35.41 to $35.65.

Footnote F3

Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021.

Footnote F4

Option award was granted on March 1, 2021 with vesting in three equal annual installments beginning March 1, 2022.

Footnote F5

Option award was granted on March 1, 2022 with vesting in three equal annual installments beginning March 1, 2023.

Footnote F6

Option award was granted on March 1, 2017 with vesting in three equal annual installments beginning March 1, 2018.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .